Horizon Pharma Company Profile (NASDAQ:HZNP)

About Horizon Pharma

Horizon Pharma logoHorizon Pharma plc, formerly Vidara Therapeutics International Public Limited Company, is a biopharmaceutical company. The Company is focused on identifying, developing, acquiring or in-licensing and commercializing differentiated products. It markets approximately nine medicines through its orphan, primary care and rheumatology business units. Its segment focuses on the identification, development, acquisition and commercialization of differentiated and accessible medicines. Its marketed medicines include ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), MIGERGOT (ergotamine tartrate and caffeine suppositories), PENNSAID (diclofenac sodium topical solution) 2% w/w, or PENNSAID 2%, RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium). It also developed DUEXIS and RAYOS, known as LODOTRA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: HZNP
  • CUSIP: 44047T10
Key Metrics:
  • Previous Close: $19.43
  • 50 Day Moving Average: $20.34
  • 200 Day Moving Average: $17.47
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 7.47
  • P/E Growth: 0.65
  • Market Cap: $3.13B
  • Outstanding Shares: 160,904,000
  • Beta: 1.92
Additional Links:
Companies Related to Horizon Pharma:

Analyst Ratings

Consensus Ratings for Horizon Pharma (NASDAQ:HZNP) (?)
Ratings Breakdown: 2 Hold Ratings, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.85)
Consensus Price Target: $30.27 (55.80% upside)

Analysts' Ratings History for Horizon Pharma (NASDAQ:HZNP)
DateFirmActionRatingPrice TargetDetails
8/23/2016GuggenheimReiterated RatingBuy$30.00View Rating Details
8/10/2016MizuhoReiterated RatingBuy$24.00 -> $30.00View Rating Details
8/10/2016BMO Capital MarketsReiterated RatingOutperform$29.00 -> $30.00View Rating Details
8/10/2016Piper Jaffray Cos.Reiterated RatingOverweight$34.00 -> $33.00View Rating Details
8/9/2016Brean CapitalReiterated RatingBuy$30.00View Rating Details
8/9/2016Citigroup Inc.Boost Price TargetNeutral$18.00 -> $21.00View Rating Details
8/4/2016Jefferies GroupReiterated RatingBuy$27.00View Rating Details
7/11/2016Morgan StanleyUpgradeUnderweight -> Equal Weight$24.00View Rating Details
7/6/2016Stifel NicolausReiterated RatingBuy$45.00View Rating Details
6/6/2016Goldman Sachs Group Inc.Initiated CoverageBuy$24.00View Rating Details
4/2/2016Cowen and CompanyReiterated RatingBuyView Rating Details
11/11/2015WallachBeth CapitalUpgradeBuyView Rating Details
10/22/2015JMP SecuritiesReiterated RatingBuyView Rating Details
7/7/2015Leerink SwannReiterated RatingPositive$37.00View Rating Details
9/9/2014Avondale PartnersInitiated CoverageOutperformView Rating Details
(Data available from 8/27/2014 forward)


Earnings History for Horizon Pharma (NASDAQ:HZNP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q216$0.50$0.62$235.43 million$257.40 millionViewN/AView Earnings Details
5/9/2016Q116$0.30$0.34$197.73 million$204.70 millionViewN/AView Earnings Details
2/29/2016Q415$0.62$0.63$240.92 million$244.50 millionViewListenView Earnings Details
11/6/2015Q315$0.40$0.70$185.70 million$292.70 millionViewListenView Earnings Details
8/7/2015Q215$0.32$0.39$156.41 million$172.80 millionViewListenView Earnings Details
5/8/2015Q115$0.21$0.21$104.20 million$113.10 millionViewN/AView Earnings Details
2/27/2015Q414$0.23$0.27$95.50 million$103.80 millionViewN/AView Earnings Details
11/6/2014Q314$0.17$0.24$73.17 million$75.10 millionViewN/AView Earnings Details
8/7/2014Q214$0.10$0.21$58.35 million$66.10 millionViewN/AView Earnings Details
5/9/2014Q114$0.01$0.16$42.69 million$51.90 millionViewN/AView Earnings Details
3/13/2014Q413($0.08)($0.22)$32.20 million$43.10 millionViewN/AView Earnings Details
11/8/2013Q3 13($0.25)($0.03)$18.31 million$31.50 millionViewN/AView Earnings Details
8/9/2013Q213($0.32)($0.24)$16.09 million$17.64 millionViewN/AView Earnings Details
5/10/2013Q113($0.35)($0.30)$9.47 million$9.20 millionViewN/AView Earnings Details
11/13/2012Q312($0.68)($0.39)$4.12 million$7.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Horizon Pharma (NASDAQ:HZNP)
Current Year EPS Consensus Estimate: $2.18 EPS
Next Year EPS Consensus Estimate: $2.6 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.58$0.58$0.58
Q2 20161$0.49$0.49$0.49
Q3 20161$0.66$0.66$0.66
Q4 20161$0.68$0.68$0.68
(Data provided by Zacks Investment Research)


Dividend History for Horizon Pharma (NASDAQ:HZNP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Horizon Pharma (NASDAQ:HZNP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/2/2016Jeffrey W. ShermanEVPSell2,900$20.00$58,000.00View SEC Filing  
6/15/2016Virinder NohriaDirectorSell25,000$17.69$442,250.00View SEC Filing  
2/26/2016Jeffrey W ShermanEVPSell4,100$20.00$82,000.00View SEC Filing  
12/10/2015Jeffrey W ShermanEVPSell4,456$20.00$89,120.00View SEC Filing  
9/21/2015Jeffrey W ShermanEVPSell7,750$31.78$246,295.00View SEC Filing  
7/15/2015Jeffrey W ShermanEVPSell26,887$35.55$955,832.85View SEC Filing  
3/13/2015Jeff HimawanDirectorSell554,564$22.44$12,444,416.16View SEC Filing  
3/10/2015Jeff HimawanDirectorSell1,614,827$21.85$35,283,969.95View SEC Filing  
11/19/2014Jeff HimawanDirectorSell3,450,000$12.05$41,572,500.00View SEC Filing  
11/19/2014Jeffrey W ShermanEVPSell24,999$12.05$301,237.95View SEC Filing  
11/19/2014Timothy P WalbertCEOSell150,000$12.05$1,807,500.00View SEC Filing  
11/13/2014Balaji VenkataramanMajor ShareholderSell6,086,957$11.54$70,243,483.78View SEC Filing  
11/13/2014Virinder NohriaDirectorSell1,739,130$11.54$20,069,560.20View SEC Filing  
9/30/2014Vaere Robert J DeCFOSell51,942$12.28$637,847.76View SEC Filing  
5/19/2014Timothy WalbertCEOSell31,742$12.94$410,741.48View SEC Filing  
5/19/2014Todd SmithEVPSell10,159$12.94$131,457.46View SEC Filing  
5/19/2014Vaere Robert DeCFOSell12,939$12.94$167,430.66View SEC Filing  
12/13/2013Jeffrey BirdDirectorBuy668,673$6.50$4,346,374.50View SEC Filing  
12/9/2013Timothy WalbertCEOSell12,124$6.79$82,321.96View SEC Filing  
12/9/2013Todd SmithEVPSell11,322$6.91$78,235.02View SEC Filing  
11/21/2013Jeffrey BirdDirectorBuy151,089$6.24$942,795.36View SEC Filing  
9/25/2012Jeffrey W BirdDirectorBuy575,356$3.49$2,007,992.44View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Horizon Pharma (NASDAQ:HZNP)
capitalcube.com logoHorizon Pharma Plc breached its 50 day moving average in a Bearish Manner : HZNP-US : August 26, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 26 at 8:32 AM
capitalcube.com logoETF’s with exposure to Horizon Pharma Plc : August 25, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 25 at 10:33 AM
feeds.benzinga.com logoWatch These 7 Huge Call Purchases In Thursday Trade (NASDAQ:HZNP)
feeds.benzinga.com - August 25 at 3:22 AM
News IconGuggenheim Reiterates Buy at Horizon Pharma Inc. (NASDAQ: HZNP) - BNB Daily (blog) (NASDAQ:HZNP)
www.baseball-news-blog.com - August 24 at 8:39 AM
marketrealist.com logoThe Word on the Street: How Do Analysts See Horizon Pharma? (NASDAQ:HZNP)
marketrealist.com - August 22 at 5:37 PM
www.leagle.com - August 19 at 8:31 AM
globenewswire.com logoHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of ... (NASDAQ:HZNP)
globenewswire.com - August 18 at 8:35 AM
finance.yahoo.com logo7:03 am Horizon Pharma announces that the USPTO has granted a NOA for a patent that covers its RAYOS (prednisone) delayed-release tablets (NASDAQ:HZNP)
finance.yahoo.com - August 18 at 8:35 AM
publicnow.com logoHorizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets (NASDAQ:HZNP)
www.publicnow.com - August 18 at 8:35 AM
finance.yahoo.com logoHORIZON PHARMA PLC Financials (NASDAQ:HZNP)
finance.yahoo.com - August 13 at 5:23 PM
capitalcube.com logoETF’s with exposure to Horizon Pharma Plc : August 12, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 12 at 5:37 PM
capitalcube.com logoHorizon Pharma Plc :HZNP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NASDAQ:HZNP)
www.capitalcube.com - August 11 at 5:46 PM
finance.yahoo.com logoNuvo Pharmaceuticals™ Announces 2016 Second Quarter Results (NASDAQ:HZNP)
finance.yahoo.com - August 10 at 5:50 PM
rttnews.com logoHorizon Pharma Inc. (HZNP) Rose Sharply On Better Than Expected Q2 Earnings (NASDAQ:HZNP)
www.rttnews.com - August 9 at 5:42 PM
finance.yahoo.com logoHorizon (HZNP) Earnings Up Y/Y, Keeps '16 View, Stock Up (NASDAQ:HZNP)
finance.yahoo.com - August 9 at 5:42 PM
rttnews.com logoHorizon Pharma Inc. (HZNP) Has Risen To A 7-Month High On Q2 Results - RTT News (NASDAQ:HZNP)
www.rttnews.com - August 9 at 8:31 AM
schaeffersresearch.com logoBuzz Stocks: Horizon Pharma PLC, Delta Air Lines, Inc., and Mattress Firm Holding Corp (NASDAQ:HZNP)
www.schaeffersresearch.com - August 8 at 5:44 PM
finance.yahoo.com logoThe way you express yourself successfully in markets (NASDAQ:HZNP)
finance.yahoo.com - August 8 at 5:44 PM
sg.finance.yahoo.com logoMattress Firm, Sotheby's, Horizon Pharma rise (NASDAQ:HZNP)
sg.finance.yahoo.com - August 8 at 5:44 PM
investorplace.com logoHorizon Pharma PLC: HZNP Stock Pops After HUGE Earnings Beat (NASDAQ:HZNP)
investorplace.com - August 8 at 12:38 PM
fool.com logoIs Horizon Pharma plc Still a Good Buy? (NASDAQ:HZNP)
www.fool.com - August 8 at 11:29 AM
nasdaq.com logoHorizon Pharma Inc. (HZNP) Has Risen To A 7-Month High On Q2 Results (NASDAQ:HZNP)
www.nasdaq.com - August 8 at 10:16 AM
sg.finance.yahoo.com logoHorizon Pharma beats 2Q profit forecasts (NASDAQ:HZNP)
sg.finance.yahoo.com - August 8 at 10:16 AM
thestreet.com logoHorizon Pharma (HZNP) Stock Pops on Q2 Beat (NASDAQ:HZNP)
www.thestreet.com - August 8 at 10:16 AM
finance.yahoo.com logoHorizon (HZNP) Beats on Q2 Earnings and Revenue Estimates (NASDAQ:HZNP)
finance.yahoo.com - August 8 at 10:16 AM
feeds.reuters.com logoBRIEF-Horizon pharma Q2 diluted earnings per share $0.09 (NASDAQ:HZNP)
feeds.reuters.com - August 8 at 7:41 AM
News IconHC Stocks Watchful: Horizon Pharma PLC (NASDAQ:HZNP), Pernix Therapeutics Holdings Inc (NASDAQ:PTX) - share market updates (press release) (NASDAQ:HZNP)
sharemarketupdates.com - August 6 at 8:25 AM
finance.yahoo.com logoCan Horizon (HZNP) Surprise Earnings Estimates in Q2? (NASDAQ:HZNP)
finance.yahoo.com - August 4 at 5:51 PM
News IconStocks Roundup - Horizon Pharma, (NASDAQ:HZNP), Keryx Biopharmaceuticals, (NASDAQ:KERX) - Financial Breaking News (press release) (NASDAQ:HZNP)
wsbreakingnews.com - August 3 at 8:47 AM
biz.yahoo.com logoHORIZON PHARMA PLC Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:HZNP)
biz.yahoo.com - August 1 at 5:25 PM
News IconHC Stocks Analysis: Horizon Pharma PLC (NASDAQ:HZNP), Pernix Therapeutics Holdings Inc (NASDAQ:PTX) - share market updates (press release) (NASDAQ:HZNP)
sharemarketupdates.com - July 29 at 8:30 AM
streetupdates.com logoAnalysts Ranking Activities: Exelixis, Inc. (NASDAQ:EXEL) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates (NASDAQ:HZNP)
www.streetupdates.com - July 29 at 8:30 AM
ftsenews.co.uk logoNew Broker Ratings For Horizon Pharma, Inc. (NASDAQ:HZNP ... - FTSE News (NASDAQ:HZNP)
www.ftsenews.co.uk - July 28 at 5:42 PM
streetupdates.com logoTwo Stocks to Watch: Horizon Pharma plc (NASDAQ:HZNP) , Hemispherx BioPharma, Inc. (NYSEMKT:HEB) - Street Updates (NASDAQ:HZNP)
www.streetupdates.com - July 27 at 8:19 AM
streetupdates.com logoTake a look at Analyst Tips: Horizon Pharma plc (NASDAQ:HZNP) , Ionis Pharmaceuticals Inc (NASDAQ:IONS) - Street Updates (NASDAQ:HZNP)
www.streetupdates.com - July 21 at 11:35 AM
streetupdates.com logoNotable Analysts Recommendation to Monitor: Humana Inc. (NYSE:HUM) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates (NASDAQ:HZNP)
www.streetupdates.com - July 20 at 8:31 AM
bizjournals.com logoMarket Updates on Drugs - Generic Equities -- Mylan, Horizon Pharma, Allergan, and Diplomat Pharmacy (NASDAQ:HZNP)
www.bizjournals.com - July 15 at 4:37 PM
marketrealist.com logoLigand Pharmaceuticals’s Performance Based on EV-to-EBITDA (NASDAQ:HZNP)
marketrealist.com - July 14 at 1:11 PM
marketrealist.com logoUnderstanding Ligand Pharmaceuticals’s PE Multiple (NASDAQ:HZNP)
marketrealist.com - July 14 at 1:11 PM
streetupdates.com logoInvestors Traded Stocks: Pfizer, Inc. (NYSE:PFE) , Horizon Pharma plc (NASDAQ:HZNP) - Street Updates (NASDAQ:HZNP)
www.streetupdates.com - July 14 at 9:03 AM
4-traders.com logoNuvo Pharmaceuticals : TM) Inc. Announces Pennsaid 2% Phase 3 Trial to Support Regulatory Approvals in the E.U., Canada and Australia (NASDAQ:HZNP)
www.4-traders.com - July 13 at 5:56 PM
marketwatch.com logoForeigners made record U.S. investments in 2015, but not for all best reasons (NASDAQ:HZNP)
www.marketwatch.com - July 13 at 10:50 AM
tradecalls.org logoShort Term Rating on Horizon Pharma plc (HZNP) - Trade Calls (NASDAQ:HZNP)
www.tradecalls.org - July 13 at 8:27 AM
smarteranalyst.com logoMorgan Stanley Weighs In on Two Biotechs: Relypsa Inc (RLYP), Horizon Pharma PLC (HZNP) - Smarter Analyst (NASDAQ:HZNP)
www.smarteranalyst.com - July 13 at 8:27 AM
publicnow.com logoNuvo Pharmaceuticals™ Inc. Announces Pennsaid 2% Phase 3 Trial to Support Regulatory Approvals in the E.U., Canada and Australia (NASDAQ:HZNP)
www.publicnow.com - July 13 at 7:43 AM
News IconHC Stocks Zone: Baxter International Inc (NYSE:BAX), Horizon Pharma PLC (NASDAQ:HZNP) - share market updates (press release) (NASDAQ:HZNP)
sharemarketupdates.com - July 12 at 5:49 PM
marketrealist.com logoCheck out Horizon’s Huge Upside Potential (NASDAQ:HZNP)
marketrealist.com - July 12 at 11:06 AM
thestreet.com logoHorizon Pharma (HZNP) Stock Rises, Morgan Stanley Upgrades (NASDAQ:HZNP)
www.thestreet.com - July 11 at 11:26 AM
News IconNoble Energy, Inc. (NYSE:NBL) & Horizon Pharma (NASDAQ:HZNP) are Hot Stocks - Money News (press release) (NASDAQ:HZNP)
www.newsismoney.com - July 9 at 5:10 PM
smarteranalyst.com logoNew Drugs for Insys Therapeutics Inc (INSY) and Horizon Pharma PLC(HZNP) Lead Analysts' Bullish Outlook - Smarter Analyst (NASDAQ:HZNP)
www.smarteranalyst.com - July 7 at 8:23 AM


Horizon Pharma (NASDAQ:HZNP) Chart for Saturday, August, 27, 2016

Last Updated on 8/27/2016 by MarketBeat.com Staff